Arrowstreet Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $524M | Buy |
|
|||||
|
2025
Q1 | $131M | Buy |
|
|||||
|
2024
Q4 | $8.96M | Sell |
|
|||||
|
2024
Q3 | $105M | Sell |
|
|||||
|
2024
Q2 | $121M | Sell |
|
|||||
|
2024
Q1 | $181M | Buy |
|
|||||
|
2023
Q4 | $25.2M | Buy |
|
|||||
|
2023
Q3 | $9.97M | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $68.3M | Buy |
|
|||||
|
2022
Q4 | $19M | Sell |
|
|||||
|
2022
Q3 | $19.5M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $159M | Sell |
|
|||||
|
2021
Q4 | $385M | Buy |
|
|||||
|
2021
Q3 | $357M | Buy |
|
|||||
|
2021
Q2 | $84.5M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $64.2M | Sell |
|
|||||
|
2020
Q1 | $123M | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $142M | Sell |
|
|||||
|
2019
Q2 | $427M | Sell |
|
|||||
|
2019
Q1 | $703M | Sell |
|
|||||
|
2018
Q4 | $767M | Buy |
|
|||||
|
2018
Q3 | $898M | Buy |
|
|||||
|
2018
Q2 | $771M | Buy |
|
|||||
|
2018
Q1 | $416M | Buy |
|
|||||
|
2017
Q4 | $398M | Buy |
|
|||||
|
2017
Q3 | $324M | Buy |
|
|||||
|
2017
Q2 | $186M | Buy |
|
|||||
|
2017
Q1 | $430K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $88.9M | Buy |
|
|||||
|
2016
Q2 | $14M | Sell |
|
|||||
|
2016
Q1 | $21.8M | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $65.3M | Sell |
|
|||||
|
2015
Q2 | $106M | Buy |
|
|||||
|
2015
Q1 | $11M | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $78.5M | Sell |
|
|||||
|
2014
Q2 | $77.7M | Buy |
|
|||||
|
2014
Q1 | $15.6M | Buy |
|